Adventa Bioscience Inc. — Form D
Adventa Bioscience Inc. of LODI, WI, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-15. The offering totals $410K, of which $410K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-15
- Form: D
- Accession: 0001897546-22-000001
- Industry: Biotechnology
- Exemptions: 06b, 4a5
- Total offering: $410K
- Amount sold: $410K
- Minimum investment: $5K
- Investors: 2
- Date of first sale: 2022-03-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-437404
Issuer
- Name: Adventa Bioscience Inc.
- CIK: 0001897546
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 925 DEVELOPMENT DRIVE, LODI, WI, 53555
- Phone: 706-372-2124
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Chip Timothy Goodman | Director | Lodi, DE |
| William Jackson | Director | Atlanta, GA |
| John Timothy Shorty | Director | Lodi, DE |
| Steven Timothy Wynne | Director | Lodi, DE |
| Peter Timothy Lamb | Executive Officer | Lodi, DE |
| Christopher Timothy Tracy | Executive Officer | Lodi, DE |
More